It has been shown that depletion of NRF-2 was associated with tumor infiltration by CD8+ and CD4+ T cells, whereas combined inhibition of NRF-2 and PD-1 demonstrated enhanced anti-melanoma effect [205]. Here, NFE2L2 is linked to melanoma.